LETTER
Once-Daily Aminoglycoside Dosing
Roger Baxter, MD
15 February 1997 | Volume 126 Issue 4 | Page 330
TO THE EDITOR:
Hatala and colleagues' meta-analysis of once daily aminoglycoside dosing [1] should be helpful and encouraging to physicians who are interested in this dosing regimen. However, the use of aminoglycosides has recently diminished with the advent of such agents as broad-spectrum cephalosporins that give adequate gram-negative coverage even for neutropenic patients. The main use of aminoglycosides in my practice is for synergy; the drugs are usually used with a ß-lactam agent for various streptococcal, enterococcal, and staphylococcal infections. In these cases, the drug is given in a lower dosage but usually two or three times per day. I would appreciate the authors' thoughts on the use and monitoring of once-daily dosing for these indications.
|
Author and Article Information
|
|---|
Kaiser Permanente, Oakland, CA 94611
1. Hatala R, Dinh T, Cook DJ. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med. 1996; 124:717-25.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.